Free Trial

Syros Pharmaceuticals (SYRS) Insider Trading & Ownership

Syros Pharmaceuticals logo
$0.02 +0.00 (+3.15%)
As of 10:21 AM Eastern

Syros Pharmaceuticals (NASDAQ:SYRS) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
12.26%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$206.49K
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$46.38K
Get SYRS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Syros Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SYRS Insider Buying and Selling by Quarter

Syros Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/2/2024Nancy A SimonianDirectorSell37,070$0.27$10,008.90  
11/25/2024Nancy A SimonianDirectorSell134,713$0.27$36,372.51  
9/12/2024Jason HaasCFOBuy45,344$1.68$76,177.92  
9/10/2024Conley CheeCEOBuy50,000$1.51$75,500.00  
9/10/2024Jason HaasCFOBuy35,363$1.55$54,812.65  
(Data available from 1/1/2013 forward)

SYRS Insider Trading Activity - Frequently Asked Questions

The list of insiders at Syros Pharmaceuticals includes Conley Chee, David Roth, Eric R Olson, Jason Haas, Nancy A Simonian, Richard A Young, Srinivas Akkaraju, and Timothy Tyson. Learn more on insiders at SYRS.

12.26% of Syros Pharmaceuticals stock is owned by insiders. Learn more on SYRS's insider holdings.

The following insiders have purchased SYRS shares in the last 24 months: Conley Chee ($75,500.00), Jason Haas ($130,990.57), and Srinivas Akkaraju ($3,999,998.34).

Insiders have purchased a total of 1,035,684 SYRS shares in the last 24 months for a total of $4,206,488.91 bought.

The following insiders have sold SYRS shares in the last 24 months: David Roth ($54,605.25), Eric R Olson ($2,411.50), Nancy A Simonian ($46,381.41), and Richard A Young ($178,365.44).

Insiders have sold a total of 221,094 Syros Pharmaceuticals shares in the last 24 months for a total of $281,763.60 sold.



This page (NASDAQ:SYRS) was last updated on 7/1/2025 by MarketBeat.com Staff
From Our Partners